![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Department of Neurology (C.-W.H.) and Institute of Clinical Medicine (C.-W.H., C.-C.H.), Department of Pediatrics (C.-C.H.), and Department of Physiology and Institute of Basic Medical Sciences (S.-N.W.), National Cheng Kung University Medical College, Tainan, Taiwan
Received November 15, 2006; accepted January 23, 2007.
| Abstract |
|---|
|
|
|---|
The large-conductance Ca2+-activated K+ (BKCa) channels, the products of a nearly ubiquitous, alternatively spliced gene (SLO or KCNMA1) (Butler et al., 1993
), are distinguished from other K+ channels in that they are gated open in response to Ca2+ binding to sites located inside of the channel, as well as by depolarized membrane potentials (Ghatta et al., 2006
; Wu et al., 2006
). Their activities provide a link between the metabolic and electrical state of cells because they are sensitive to stimulation by increased intracellular Ca2+. BKCa channels in hippocampal pyramidal cells have been identified for their collaborative effect with voltage-gated K channels in repolarizing spike and fast after hyperpolarization (Storm, 1990
; Shao et al., 1999
). In addition, riluzole and cilostazol have been reported to enhance the activity of BKCa channels in pituitary tumor (GH3) cells (Wu and Li, 1999
; Wu et al., 2004
).
A recent study has demonstrated that mutation of the pore-forming
-subunit of BKCa channels could cause generalized epilepsy, paroxysmal dyskinesia (Du et al., 2005
), and mental deficiency disorder such as autism (Laumonnier et al., 2006
). In addition, the increased activity of BKCa channels, possibly associated with the peripheral antinociceptive action of metamizol and meloxicam (Ortiz et al., 2003
, 2005
), could counteract the deleterious effects of excitatory neurotransmitters following neurotoxic or ischemic injuries as well (Gribkoff et al., 2001
; Ghatta et al., 2006
). However, it remains unknown whether ZNS, as a potential neuropsychiatric modulator, produces any effects on the activity of these channels.
The hippocampal neuron-derived H19-7 cell line is known to possess the characteristics of hippocampal neurons (Morrione et al., 2000
; Bhargava et al., 2002
). This cell line has been used for studies on the development, plasticity, and commitment in hippocampal neurons (Morrione et al., 2000
; Bhargava et al., 2002
). Therefore, the goals of this study were to examine the effect of ZNS on K+ outward current in differentiated hippocampal H19-7 cells, to address the issue of whether this drug can affect the activity and kinetic properties of BKCa channels, and to determine whether it affects other types of ion currents present in these cells. Interestingly, these results indicate that ZNS can directly enhance the activity of BKCa channels.
| Materials and Methods |
|---|
|
|
|---|
Cell Differentiation. For differentiation experiments, hippocampal H19-7 cells were plated at a density of 105 cells/35-mm plate in a medium containing serum at 34°C. After 18 h, the cells were washed extensively and then shifted to a nonpermissive temperature (39°C) in N2 serum-free medium (i.e., Dulbecco's modified Eagle's medium-high glucose medium supplemented with 0.11 mg/ml sodium pyruvate, 2 mM glutamine, 0.1 mg/ml transferrin, 20 nM progesterone, 0.1 mM putrescine, and 30 nM sodium selenite), supplemented with 50 ng/ml insulin-like growth factor-I (Life Technologies, Grand Island, NY). After 48 h, the cells were harvested and observed for neurite formation and subsequent electrophysiological experiments (Kim et al., 1997
; Morrione et al., 2000
). Therefore, rat hippocampal neurons-derived H19-7 cells could either proliferate at the permissive temperature of 34°C in response to insulin-like growth factor or differentiate to a neuronal phenotype in N2 medium at the nonpermissive temperature of 39°C (Kim et al., 1997
; Morrione et al., 2000
; Huang et al., 2006
).
Electrophysiological Measurements. Immediately before each experiment, differentiated H19-7 cells were dissociated, and an aliquot of cell suspension was transferred to a recording chamber positioned on the stage of an inverted microscope (DM IL; Leica Microsystems, Wetzlar, Germany). Cells were bathed at room temperature (2025°C) in normal Tyrode's solution containing 1.8 mM CaCl2. The recording pipettes were pulled from Kimax-51 glass capillaries (Kimble Glass, Vineland, NJ) using a two-stage microelectrode puller (PP-830; Narishige, Tokyo, Japan), and the tips were fire-polished with a microforge (MF-83; Narishige). When filled with pipette solution, their resistance ranged between 3 and 5 M
. Ion currents were recorded in a whole-cell or inside-out configuration of the patch-clamp technique, using an RK-400 patch-clamp amplifier (Bio-Logic, Claix, France) (Huang et al., 2006
). All potentials were corrected for liquid junction potential, a value that would always develop at the tip of the pipette when the composition of the pipette solution was different from that in the bath. Tested drugs were applied through perfusion or added to the bath to obtain the final concentration indicated.
Data Recordings and Analyses. The signals consisting of voltage and current tracings were displayed on an analog/digital oscilloscope (HM 507; Hameg Inc., East Meadow, NY). The data were stored online in a laptop computer through an analog/digital interface (Digidata 1322A; Molecular Devices, Union City, CA), controlled by a commercially available software package (pCLAMP 9.0; Molecular Devices). The sampling rate for electrophysiological measurements was 10 kHz. Currents were low-pass filtered at 1 or 3 kHz. Ion currents recorded during experiments were stored and analyzed subsequently using pCLAMP 9.0 software (Molecular Devices), Origin 7.5 software (Microcal Software, Inc., Northampton, MA), SigmaPlot 7.0 software (SPSS, Inc., Apex, NC), or custom-made macros in Excel 2003 (Microsoft, Redmond, WA). The pCLAMP-generated voltage-step protocols were generally used to examine the current-voltage (I-V) relations for ion currents.
To calculate concentration-dependent stimulation of ZNS on the activity of BKCa channels, H19-7 cells were bathed in a high-K+ (145 mM) solution, and inside-out configuration was performed. Each excised patch was held at +60 mV, and the bath medium contained 0.1 µM Ca2+. The concentration-dependent effect of ZNS at different concentrations (3100 µM) was fitted with a Hill function. That is, relative open probability = (Emax x [C]nH)/(EC50nH + [C]nH), where [C] represents the ZNS concentration, nH and EC50 are Hill coefficients and the ZNS concentration needed to increase channel activity by 50%, respectively; and Emax is the ZNS-induced maximal stimulation of BKCa channels.
Single-channel currents of BKCa or KATP channels were analyzed using pCLAMP 9.0 software (Molecular Devices). Multigaussian adjustments of the amplitude distributions between channels were used to determine unitary currents. The functional independence between channels was verified by comparing the observed stationary probabilities with the values calculated according to binomial law. The number of active channels in the patch N was counted at the end of each experiment and then used to normalize opening probability at each potential. The open probabilities were evaluated using an iterative process to minimize the
2 calculated with a sufficiently large number of independent observations. The open or closed distribution of the channel was fit with a one- or two-exponential function.
The plots of the open probability of BKCa channels as a function of membrane potential were constructed and fit with a Boltzmann function using nonlinear regression analysis with the Origin 7.5 (Microcal). That is, relative open probability = np/{1 + exp[ (V V1/2)/k]}, where np = the maximal probability of channel openings, V = the membrane potential in mV, V1/2 = the membrane potential for half-maximal activation, and k = the slope factor of the activation curve.
The averaged results are presented as the mean values ± S.E.M. The paired or unpaired Student's t test and one-way analysis of variance with the least significance difference method for multiple comparisons were used for statistical evaluation of the differences among the mean values. Differences between values were considered significant when p < 0.05 or <0.01.
Drugs and Solutions. Zonisamide (Zonegran) was kindly provided by Dainippon Pharmaceuticals (Osaka, Japan). Riluzole was obtained from Tocris Cookson Ltd. (Bristol, UK). Tetraethylammonium chloride and tetrodotoxin were purchased from Sigma Chemical (St. Louis, MO), apamin and iberiotoxin were from Alomone Laboratories (Jerusalem, Israel), and paxilline was from Biomol (Plymouth Meeting, PA) (Wu et al., 2006
). All other chemicals were commercially available and of reagent grade. The twice-distilled water that had been deionized through a Millipore-Q system (Millipore Corporation, Billerica, MA) was used in all experiments.
The composition of normal Tyrode's solution was 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES-NaOH buffer, pH 7.4. To record K+ currents, a patch pipette was filled with a solution consisting of 140 mM KCl, 1 mM MgCl2, 3 mM Na2ATP, 0.1 mM Na2GTP, 0.1 mM EGTA, and 5 mM HEPES-KOH buffer, pH 7.2. To record Ca2+ current, KCl inside the pipette solution was replaced with equimolar CsCl, and pH was adjusted to 7.2 with CsOH. In single-channel recordings, high-K+ bathing solution contained 145 mM KCl, 0.53 mM MgCl2, and 5 mM HEPES-KOH, pH 7.4, and the pipette solution contained 145 mM KCl, 2 mM MgCl2, and 5 mM HEPES-KOH, pH 7.2.
Mathematical Modeling. Spontaneous discharge of neurons was simulated using the model of hippocampal CA3 pyramidal neurons, which was originally derived from Pinsky and Rinzel (1994
). The important role of CA3 neurons in kindling and temporal lobe seizures has been established (Jang et al., 2006
). This model consists of a fast and transient Na+ current, a persistent, depolarization-activated Na+ current, a low-threshold Ca2+ current, a high-threshold Ca2+ current, a Ca2+-activated K+ current, a transient outward K+ current, a slowly inactivating K+ current, and a hyperpolarization-activated cation current. The source file for this model is readily available at http://cams.njit.edu/~vbooth/. The solutions to the different sets of ordinary differential equations in the simulations were approximated using the X-Win32 version of XPPAUT on a Dell Precision 670 workstation (Round Rock, TX) (Ermentrout, 2002
; Wu and Chang, 2006
). The conductance values and reversal potentials used to solve the set of differential equations are lised in Table 1.
|
| Results |
|---|
|
|
|---|
|
Stimulatory Effect of ZNS on the Activity of BKCa Channels in Differentiated H19-7 Cells. Paxilline and iberiotoxin, known inhibitors of BKCa channels, could reverse ZNS-stimulated IK. The increased macroscopic IK could be due to the increased open probability, an increase in the number of active channels, or both. The effect of ZNS on BKCa channel activity in these cells was further investigated (Fig. 2). In these experiments, single-channel recordings with an inside-out configuration were performed in symmetrical K+ solution (145 mM) (Fig. 2A). Bath medium contained 0.1 µM Ca2+, and holding potential was held at +60 mV. When ZNS (100 µM) was applied to the intracellular surface of the excised patch, the channel activity was significantly increased to 0.015 ± 0.004 (n = 5) from a control of 0.004 ± 0.001 (n = 5, p < 0.05). A further application of paxilline (1 µM) could decrease the channel activity to 0.005 ± 0.001 (n = 5). The channel activity in paxilline (1 µM) alone was 0.003 ± 0.001 (n = 5). Application of ZNS (31000 µM) was found to enhance the probability of channel openings in a concentration-dependent manner. The half-maximal concentration required for the stimulatory effect of ZNS on BKCa channel activity was 34 µM, and Hill coefficient was 1.2. Thus, the ZNS-induced increase in the amplitude of IK in these cells could be associated with its increase in the open probability of BKCa channels, rather than changes in the number of active channels.
|
|
Effect of ZNS on the Activation Curve of BKCa Channels. Figure 3B shows the activation curve of BKCa channels in the absence and presence of ZNS (30 µM). The plot of open probability of channel openings as a function of membrane potential was fitted with a Boltzmann function as described under Materials and Methods. In control, np = 1, V1/2 = 56 ± 5 mV, and k = 11.6 ± 2.1 mV (n = 6), whereas in the presence of ZNS (100 µM), np = 1.6 ± 0.2, V1/2 = 42 ± 6 mV, and k = 11.5 ± 1.9 mV (n = 6). The data thus indicate that the ZNS-increased channel activity can be accompanied by a significant shift of the steady-state activation toward less positive potentials, although the slope factor of activation curve remained unaltered. Taken together, ZNS applied to the intracellular surface of the channel is capable of affecting the activation curve with no change in the gating charge of these channels.
Effect of Internal Ca2+ Concentrations on ZNS-Stimulated BKCa Channel Activity. We next examined whether the ZNS-induced increase in the activity of these channels is associated with the level of internal Ca2+ concentrations. In these experiments, when an excised patch was formed, various concentrations of Ca2+ in the bath before and during exposure to ZNS (30 µM) were applied. As shown in Fig. 3C, the extent of ZNS-stimulated BKCa channels was not altered by changes in the level of intracellular Ca2+ concentration. For example, at the level of +60 mV, ZNS (30 µM) increased the open probability at an internal Ca2+ concentration of 0.1, 1, and 10 µM to a similar magnitude (i.e., 1.6-fold).
Effect of ZNS on Kinetic Behavior of BKCa Channels in Differentiated H19-7 Cells. The effect of ZNS on mean open and closed time of BKCa channels in these cells was examined and analyzed during recordings from patches showing only single-channel openings. As shown in Fig. 4, in control cells, the closed time histogram of BKCa channels at +60 mV can be fitted by a two-exponential function with a mean closed time of 5.2 ± 0.9 and 54.5 ± 1.6 ms (n = 5). ZNS (30 µM) decreased the lifetime of the closed time to 3.2 ± 0.8 and 19.6 ± 1.1 ms (n = 5, p < 0.05). However, no change in the component of open time distribution was observed in the presence of ZNS (30 µM) (1.62 ± 0.05 versus 1.64 ± 0.04 ms, n = 5, p > 0.05). Taken together, the data suggest that the stimulation by this drug of BKCa channels in these cells is largely due to an increase in open probability accompanied by the decreased closed time.
|
Effect of Riluzole on BKCa Channels in Differentiated Hippocampal H19-7 Cells. Riluzole has been previously reported as stimulating BKCa channels (Wu and Li, 1999
). We also examined whether the stimulatory effects of ZNS and riluzole on these channels are additive. Interestingly, as shown in Fig. 5, riluzole (30 µM) increased the channel open probability; however, a subsequent application of ZNS (30 µM) did not increase the channel activity further. Riluzole (30 µM) significantly increased the probability of channel openings from 0.12 ± 0.02 to 0.24 ± 0.03 (n = 6, p < 0.05). There was no significant difference in channel activity between the presence of riluzole alone and ZNS plus riluzole [0.24 ± 0.03 (n = 6) versus 0.23 ± 0.03 (n = 6), p > 0.05]. However, application of cilostazol (30 µM) could increase the open probability further when ZNS or riluzole was continuously present in the bath. Cilostazol was reported as an opener of BKCa channels (Hong et al., 2003
; Wu et al., 2004
). Taken together, the results led us to suggest that riluzole potentially occluded the effect of zonisamide, although these two drugs can be effective in enhancing channel activity.
|
Effect of ZNS on Voltage-Dependent L-Type Ca2+ Current in Differentiated H19-7 Cells. The question may arise whether a ZNS-induced increase in whole-cell IK is associated with an increased Ca2+ influx through voltage-dependent Ca2+ channels. ZNS has been previously reported as blocking Ca2+ current (Suzuki et al., 1992
). The effect of ZNS on the amplitude of L-type Ca2+ current (ICa,L) in differentiated H19-7 cells was thus assessed. In these experiments, cells were bathed in normal Tyrode's solution containing 1.8 mM CaCl2, and the recording pipettes were filled with Cs+-containing solution. Cell exposure to ZNS (30 µM) did not affect the peak amplitude of ICa,L. However, ZNS at a concentration of 300 µM resulted in a decrease in ICa,L (Fig. 6). For example, when cells were depolarized from 50 to 0 mV, the peak amplitude of ICa,L was slightly but significantly decreased from 85 ± 12 to 79 ± 11 pA (n = 5, p < 0.05). In addition, a further application of nifedipine (0.3 µM), a known blocker of ICa,L, almost abolished the amplitude of ICa,L. Thus, the results indicate that this drug can stimulate Ca2+-activated K+ current in a manner unlikely to be associated with an increase in the amplitude of ICa,L.
|
|
Effects of ZNS on Repetitive Firing of Action Potentials in Modeled Hippocampal CA3 Pyramidal Neurons. To determine how ZNS alters the discharge pattern of hippocampal neurons and to address questions that are difficult to be experimentally studied, a simulation model, originally derived from Pinsky and Rinzel (1994
), was also implemented. ZNS has been previously reported to block voltage-dependent Na+ current (INa) (Schauf, 1987
; Leppik, 2004
). In this modeled neuron, when the INa conductance was decreased from 18 to 17 nS, the peak amplitude of INa was readily reduced, along with the decreased firing of action potentials (Fig. 8A). When the conductance of Ca2+-activated K+ current was increased from 20 to 40 nS, the frequency of action potential firing was further reduced (Fig. 8B). As a result, the reduced INa and the increased Ca2+-activated K+ current, which mimics the ZNS action, can combine to cause a reduction in the firing of neuronal action potentials. The simulation results can be used to predict that the activity of BKCa channels could contribute to the electrical behavior of hippocampal neurons.
|
| Discussion |
|---|
|
|
|---|
The concentration-dependent stimulation of BKCa channel activity with an EC50 value of 34 µM was observed in the presence of ZNS. This concentration of ZNS is compatible with clinically relevant concentrations, ranging from 50 to 200 µM (Peters and Sorkin, 1993
; Tasaki et al., 1995
; Oommen and Mathews, 1999; Huang et al., 2005
). The observed effect of ZNS in this study is likely to occur at a concentration achievable in humans. It is thus reasonable to assume that BKCa channels present in neurons are a relevant "target" for the action of ZNS. The ability of ZNS to activate BKCa channels may constitute an important component regulating neuronal function, aiding in understanding the broad-spectrum efficacy in epilepsy and various neuropsychiatric disorders.
Our study demonstrates that ZNS does not modify single-channel conductance of BKCa channels, although it increases the channel open probability significantly. The increased amplitude of macroscopic IK is thought to be primarily due to the increased probability of channel openings accompanied by a decrease in mean closed time. In addition, when applied to the internal face of the membrane, it did not merely increase the activity of BKCa channels in the patch but also increased a shift of voltage sensitivity of the channel to less positive potentials. The sensitivity to this drug in neurons would be thus expected to depend on the preexisting level of resting potential, the firing rate of action potentials, or the ZNS concentration used.
It is noteworthy that, unlike the molecule of cilostazol, ZNS was found to possess an intramolecular hydrogen bond with a short interatomic distance and an aromatic ring poor of electrons, the properties of which are shared by other inhibitors of carbonic anhydrase (Tricarico et al., 2004
). The present results also demonstrate that the stimulatory effect of ZNS and riluzole on the activity of BKCa channels is not additive. Riluzole has been previously reported as an opener of BKCa channels in pituitary tumor (GH3) cells (Wu and Li, 1999
). It is likely that these two components, which are structurally related, may interact with the same binding site in the channel.
Previous reports have shown that some of the indole diterpenes, which are potent inhibitors of BKCa channels, are associated with their tremorogenic activity (Knaus et al., 1994
; Smith et al., 1997
). Recent reports have demonstrated that compared with
blocker, zonisamide is effective in treating essential tremor (Morita et al., 2005
; Ondo, 2006
). Further studies are needed to determine the extent to which ZNS-stimulated activity of BKCa channels contribute to its treatment of essential tremor.
ZNS at a concentration greater than 100 µM was found to block IA in differentiated hippocampal H19-7 neurons. Lack of A-type K+ channels has been proposed to decrease the seizure threshold in the cortical malformation of methylazoxymethanol-exposed rats (Castro et al., 2001
). Although no report on ZNS-worsening seizures has been noted, ZNS has been recently reported to improve depressive symptoms in bipolar disorders (Ghaemi et al., 2006
). Whether its inhibition of the IA channels has potential psychotropic benefits in treating underlying cellular disturbances in bipolar disorders, as described previously, remains to be further clarified.
Our simulation results also imply that both blockade of INa and direct stimulation of BKCa channels caused by ZNS may synergistically act to affect the functional activity of hippocampal neurons in vivo. Taken together, in addition to the blockade of INa, our results lead us to suggest that ZNS-mediated antiepileptic action could be partly associated with the direct stimulation of BKCa channels expressed in hippocampal neurons.
| Acknowledgements |
|---|
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
ABBREVIATIONS: ZNS, zonisamide, 3-sulfamoylmethyl-1,2-benzisoxazole; BKCa, large-conductance Ca2+-activated K+; riluzole, 2-amino-6-trifluoromethoxybenzothiazole; I-V, current-voltage; IK, K+ outward current; ICa,L, L-type Ca2+ current; IA, A-type K+ current; INa, Na+ current; Pax, paxilline.
Address correspondence to: Dr. Sheng-Nan Wu, Department of Physiology, National Cheng Kung University Medical College, 1 University Road, Tainan 70101, Taiwan. E-mail: snwu{at}mail.ncku.edu.tw
| References |
|---|
|
|
|---|
Baulac M (2006) Introduction to zonisamide. Epilepsy Res 68S: S3S9.
Bhargava A, Mathias RS, McCormick JA, Dallman MF, and Pearce D (2002) Glucorticoids prolong Ca2+ transients in hippocampal-derived H19-7 neurons by repressing the plasma membrane Ca2+-ATPase-1. Mol Endocrinol 16: 16291637.
Butler A, Tsunoda S, McCobb DP, Wei A, and Salkoff L (1993) mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science (Wash DC) 261: 221224.
Castro PA, Cooper EC, Lowenstein DH, and Baraban SC (2001) Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformation and epilepsy. J Neurosci 21: 66266634.
Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, Wang L, Kotagal P, Luders HO, Shi J, Cui J, et al. (2005) Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 37: 733738.[CrossRef][Medline]
Ermentrout GB (2002) Simulating, Analyzing, and Animating Dynamical System: A Guide to XPPAUT for Researchers and Students, Society for Industrial and Applied Mathematics, Philadelphia, PA.
Ghaemi SN, Zablotsky B, Filkowski MM, Dunn RT, Pardo TB, Isenstein E, and Baldassano CF (2006) An open prospective study of zonisamide in acute bipolar depression. J Clin Psychopharmacol 26: 385388.[CrossRef][Medline]
Ghatta S, Nimmagadda D, Xu XP, and O'Rourke ST (2006) Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 110: 103116.[CrossRef][Medline]
Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7: 471477.[CrossRef][Medline]
Hong KW, Kim KY, Shin HK, Lee JH, Choi JM, Kwak YG, Kim CD, Lee WS, and Rhim BY (2003) Cilostazol prevents tumor necrosis factor-
-induced cell death by suppression of phosphatase and tension homolog deleted from chromosome 10 phosphorylation and activation. J Pharmacol Exp Ther 306: 11821190.
Huang CW, Huang CC, Liu YC, and Wu SN (2004) Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells. Epilepsia 45: 729736.[CrossRef][Medline]
Huang CW, Huang CC, and Wu SN (2006) The opening effect of pregabalin on ATP-sensitive potassium channels in differentiated hippocampal neuron-derived H19-7 cells. Epilepsia 47: 720726.[CrossRef][Medline]
Huang CW, Ueno S, Okada M, and Kaneko S (2005) Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex. Epilepsy Res 67: 5160.[CrossRef][Medline]
Jang IS, Nakamura M, Ito Y, and Akaike N (2006) Presynaptic GABAa receptors facilitate spontaneous glutamate release from presynaptic terminals on mechanically dissociated rat CA3 pyramidal neurons. Neuroscience 138: 2535.[CrossRef][Medline]
Kim B, Leventhal PS, Saltiel AR, and Feldman EL (1997) Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J Biol Chem 272: 2126821273.
Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, and Smith AB 3rd (1994) Tremorogenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33: 58195828.[CrossRef][Medline]
Laumonnier F, Roger S, Guerin P, Molinari F, M'rad R, Cahard D, Belhadj A, Halayem, Persico AM, Elia M, et al. (2006) Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am J Psychiatry 163: 16221629.
Leppik IE (2004) Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 13: S5S9.
Morita S, Miwa H, and Kondo T (2005) Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 11: 101103.[Medline]
Morrione A, Romano G, Navarro M, Reiss K, Valentinis B, Dews M, Eves E, Rosner MR, and Baserga R (2000) Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer Res 60: 22632272.
Ondo WG (2006) Essential tremor: treatment options. Curr Treat Options Neurol 8: 256267.[Medline]
Oommens KJ and Mathews S (1999) Zonisamide: a new anti-epileptic drug. Clin Neuropharmacol 22: 192200.[Medline]
Ortiz MI, Castañeda-Hernández G, and Granados-Soto V (2003) Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels. Pharmacol Biochem Behav 74: 465470.[CrossRef][Medline]
Ortiz MI, Castañeda-Hernández G, and Granados-Soto V (2005) Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test. Pharmacol Biochem Behav 81: 725731.[CrossRef][Medline]
Peters DH and Sorkin EM (1993) Zonisamide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 45: 760787.[Medline]
Pinsky PF and Rinzel J (1994) Intrinsic and network rhythmogenesis in a reduced Traub model for CA3 neurons. J Comput Neurosci 1: 3960.[CrossRef][Medline]
Rock DM, Macdonald RL, and Taylor CP (1989) Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant. Epilepsy Res 3: 138143.[CrossRef][Medline]
Schauf CL (1987) Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 413: 185188.[CrossRef][Medline]
Shao LR, Halvorsrud R, Borg-Graham L, and Storm JF (1999) The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J Physiol (Lond) 521: 135146.
Smith BL, McLeay LM, and Embling PP (1997) Effect of the mycotoxins penitrem, paxilline and lolitrem B on the electromyographic activity of skeletal and gastrointestinal smooth muscle of sheep. Res Vet Sci 62: 111116.[CrossRef][Medline]
Storm JF (1990) Potassium currents in hippocampal pyramidal cells. Prog Brain Res 83: 161187.[Medline]
Suzuki S, Kawakami K, Nishimura S, Watanabe Y, Yagi K, Seino M, and Miyamoto K (1992) Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 12: 2127.[CrossRef][Medline]
Tasaki K, Minami T, Ieiri I, Ohtsubo K, Hirakawa Y, Ueda K, and Higuchi S (1995) Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding. Brain Dev 17: 182185.[CrossRef][Medline]
Tricarico D, Barbieri M, Mele A, Carbonara G, and Camerino DC (2004) Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. FASEB J 18: 760761.
Wu SN and Chang HD (2006) Diethyl pyrocarbonate, a histidine-modifying agent, directly stimulates activity of ATP-sensitive potassium channels in pituitary GH3 cells. Biochem Pharmacol 71: 615623.[CrossRef][Medline]
Wu SN and Li HF (1999) Characterization of riluzole-induced stimulation of large-conductance calcium-activated potassium channels in rat pituitary GH3 cells. J Investig Med 47: 484495.[Medline]
Wu SN, Liu SI, and Huang MH (2004) Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells. Endocrinology 145: 11751184.
Wu SN, Wu AZ, and Lin MW (2006) Pharmacological roles of the large-conductance calcium-activated potassium channel. Curr Top Med Chem 6: 10251030.[CrossRef][Medline]
Yoshida S, Okada M, Zhu G, and Kaneko S (2005) Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors. Epilepsy Res 67: 153162.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||